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Chapter I
INTR ODUCTI 00'

i

Evidence for Chemical Transmission

l

i

I

Over the past twenty five years there has been an accumulation of

'much data which provides evidence for chemical transmission in the peri-

l

ipheral nervous system (Dale, 1938; Katz anq Miledi, 1962; Hebb and
Smallmon, 1957; Whittaker and Sheridan, 1965; Wilson and Ginsburg, 1955;
Krupa, 1963; Von Euler, 1966; Curtis, 1964).

However, data pertaining to

the role of chemicals as transmitters in the central nervous system (CNS)
has been more difficult to accrue due to the anatomical and physiological
complexities of these parts (Eccles, 1964).
Generally, satisfaction of the following criteria is considered
proof of transmitter function:
1) nte proposed substance must be identified as being present in
neural tissue in question; 2) nte

substanc~

must be released and

must produce a physiological effect upon stimulation; 3) An enzymatic
system of synthesis and degradation must be present to produce a constant
supply of the substance; 4) ntere should be storage mechanisms present
in the area in question; 5) Neurons receptive to the substance must be
demonstrated - and finally; 6) Pharmacological analysis should demonstrate
t

la similarity between exogenously applied and endogenously released transt
lmitter substance.

b

When the data relevant to the transmitter role of a compound such as

;

j

repinephrine in the central nervous system is compared with that of

,......,,.,..,._.,,.-.,,)-·----------------------

I
l
I
·---ii

2

jacetylcholine at the peripheral synapses, the proof of the transmitter
I'

)role of norepinephrine centrally is not conclusive.
!
!

f

This evidence suggesting a central transmitter role for norepine-

'phrine includes the following observations:

1) There are regional brain

!differences in the distribution of norepinephrine which appear to be
related to certain neurophysiological sub-systems of the nervous system

f (Rech et al., 1966; Van Rossum, 196 7).

2) ·High levels of the enzymes

related to the synthesis of norephinephrine are associated with structures
that look like synaptice vesciles (Michaelson et al., 1963; De Robertis,

11966).

3) By fluorescent techniques catecholamines have been localized

to the CNS {Dahlstrom and Fuxe, 1964; Fuxe, 1965; Falck et al., 1962).

4) Fluorometric analysis of whole brain amines {Shore and Olin, 1960;
Weigen and Pery, 1961; Everett, 1961) have also documented the presence
of catecholamines centrally.

5) Induced neural activity changes brain

norepinephrine levels (Reis and Gunne, 1965).

6} Microiontophoresis and

intraventricular administration of the amines and substances relating to
their synthesis and degradation have electrophysiological and behavioral
effects.
There are many technical problems involved with any attempt to use
the peripheral nervous system as a model for studying a possible transmitter in the central nervous

sy~tem.

'

I

The dendrites are numerous and

small, and packed within a tangle of glia.

I

This makes isolation and

I

chemical and physical manipulation very difficult.

There are, of course,

neural tracts and specific areas of known physiological activity (Fuxe
et al., 1965).

However, the separation and identification of separate

I

. ---------------------------·;i1rc .

t.---------~-•-•w•·-

.J

3

neuron cell bodies is extremely difficult.
It is difficult but possible to obtain by activation of neural tracts
and areas in the central nervous system discrete, replicable, physiological phenomena such as the miniature end-plate potential obtained by
fsuitable electrode placement in the peripheral nervous system (Eccles,
!1964).
l'
i

!i

Catecholamines as Modulators

The administration of drugs which have been found to affect levels

lof the amines in the central nervous system and which also affect befhavior has led to numerous speculations based on a supposed transmitter
Jand/or modulator role of the catecholamines and serotonin (Everett, 1961;

•j Everett

and Weigard, 1962).

These speculations often are present as

'hypothesis relating behavioral states to the adrenergic, cholinergic,
'
1
dopaminergic, serotonergic, etc., "systems of the brain". An investi-

i

1gatiort

into the role of adrenergic and serotonergic systems in behavior

I

iis the basis of the research presented in this thesis.

[

Catecholamine Metabolism
Catecholamines are low-molecular-weight substances which contain a

j

jcatechol nucleus and an amine group.

The more cOIIElonly studied catecholes

l•re dihydroxyphenylalanine (dopa) and its metabolic products, dopamine,
lnorepinephrine and epinephrine.
1

These compounds are synthesized from

their precursor, tyrosine by a known series of enzymatic reactions.

The

!

:amino acid tyrosine, normally present in the circulation, is concentrated

I

l in

neural tissue by an active transport mechanism.

Tntraneuronally

I

f tyrosine
I

undergoes three specific enzymatic transformations which result

,,.,,,....,....,1"-IW-•-------.-~...,.y,.,;,,..,.....,._.,.,.-•~

_,,.~._...._...._~_,

---·lt . -,,., . .,. . ., . . . _. . . ,., ,.. ,. ._, .
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·in the production of norepinephrine.

In those cells which contain the

.enzyme needed to snythesize epinephrine, there is an additional intra!cellular migration of norepinephrine, from the granule to the cytoplasm
I

ifor N-methylation, and then back again to the chromaffin granule for
f
,l

storage.

I

The following is a diagram which illustrates the biosynthesis

!of catecholamines in brain, chromaffin cells (adrenal medulla) and

I

lsympathetic nerve endings (Fig. 1).

f

Serotonin Metabolism

'

I

Serotonin (5HT) is an indol amine which is synthesized in the brain

I from

'j

the amino acid tryptophan.

The following is a diagram which ill-

lustrates the biosynthesis of serotonin (5HT) (Fig. 2).

I

The catecholamines are degraded by the enzymes monoamine oxidase

;and catechol-o-methyl transferase.

Ilenzyme. monoamine oxidase.

Serotonin is also degraded by the

Drugs which affect each of these enzymes will

f be considered in the following chapter as they affect the brain levels of
ithe amines and serotonin (Chapter II, d).
!
Catecholamines, Serotonin and Behavior

J

I

The causal effects of brain catecholamine levels and serotonin

'levels on behavior have not been clearly substantiated.
1 statements are examples from published papers.

The following

"A case can be made for

·f

f the catecholamines having either central excitant or central depressant

Iactions"

(Marley, 1966).

"With the facts so far available it is not

'possible to say what function dopamine has in the central nervous system",

I
!

(Bertles and Rosengren, 1966).

i in
i

An still in reference to psychiatric states

humans, the evidence as a whole does not permit assigning importance to

l.. "-~---·;;~."-....~~-.~,_,_.___,, ,_,,-...,."·~<!..·~,--··-I
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~

I

Biosynthesis of Serotonin

I
I

i

I
ll
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i

!

I

the catecholamines specifically" (Kety, 1966).
Dr. Dews in a symposium on catecholamines stated that studies of the

~

!effects of Biogenic Amines on Operant Behavior show that the complex be'havioral output of an intact animal can be effectively used to study drug
I

f interactions and antagonisms.

He concluded, hc;wever, that "studies of

l

ltransmitters and related compounds have shown that patterns of behavior as
la whole tend to be suppressed or enhanced, without specific reference to
~individual

I

components of the behavior" (Dews, 1968).

This attitude ·is not shared by all iuvestigators, however.

Frequently

ja direct relationship is implied when a behavioral state is found along
I.with altered amine levels as the result of drug administration.
I

A direct

correlation for example between psychosis and serotonin is presumed by

Some drugs which significantly alter the brain levels of biogenic
!amines
in animals also produce changes in behavior.
!.

A classical example

l
f of this is reserpine which produces many behavioral effects, such as
t

jsedation, a loss of conditioned avoidance, a decrease in self stimulation,

f and

a behavioral state in rats analogous to clinical endogenous depression

f
jinman (Kety, 1967a).

A remarkable correlation persists between the action

'

I

jor reserpine and its effect on catecholamines suggesting that the action

lof reserpine on behavior is dependent on its effects on the central amines
f (Kety, 1962).

f

Because drugs such as reserpine and monoamine oxidase inhibitors affect

L. ._.. . ,"-·-....,.,..-.~-.~ ---~.··-··---------------------·-··· .,. . ,.~~. .,.J

8

;more than one amine similarly, they have not been useful in relating
;£.articular amines to their behavioral effects.

Other drugs such as

'

'
'specific
precursors, and specific inhibitors have been of greater value.

i
!

1 Th.ere

will be discussed in detail with regard to their phannacological

;

'

!activity and effects on behavior in the following chapters.
lI
!
-"-Methyl-p-tyrosine, which blocks tyrosine hydroxylase and lowers
!brain catecholamine levels but not at all 5HT levels, has been reported

Ito produce sedation in man (Sjoerdsma et al., 1965).
l
I

P-Chlorophenylalanine, which blocks the synthesis of SHT in the

!

'
f

)brain without affecting other amines such as norepinephrine or dopamine,

l
i

Jhas been examined for its effects on behavior.

It does not appear to

!produce sedation even though SHT is reduced to minimal levels in the brain
i

I (Koe

and Weissman, 1966).
Most drugs which rather specifically alter affective states in man

iand behavior in animals have been shown to interact in some manner with

f

tbiogenic amines in the brain.
Reserpine which was used in psychiatry in the treatment of mania and

l

lexcitement prior to the introduction of the phenothiazines and is used

Iiin
i
i

general medicine in the treatment of hypertension has been reported to

)produce severe depression of mood in some patients, particularly hyper-

f tensive patients treated with relatively large doses (Glowinski et al.,

Iil965).
:

~
Depression has also been observed in patients given tetrabenazine,

}a drug which is similar to reserpine in its effects on biogenic amine

~metabolism

(Lingjaerde, 1963).

The effects of reserpine have been extensively studied in experi-

9

<

imental animals and in-vitro systems.

By a mechanism which has not yet

i.

been completely elucidated, reserpine interfers with the intraneuronal

ibinding
of the catecholamines and serotonin (Carlsson et al., 1957). With
i
~the binding thus impaired the amines may diffuse freely through the cyto~

jplasm and attach to mitrochondrial monoamine oxidase.

This results in

!

itheir inactivation by deamination and thus, in depletion of tissue amine
I

)stores.

Reserpine-induced sedation in

ani~ls

is associated with decreased

I

Ii

lbrain levels of norepinephrine, dopamine and serotonin (Carlsson et al.,

I

1963).

''

·I

There have been reports of a temporal association between the return

I9of normal motor behavior

in animals sedated wit h reserpine an d t h e restor-

ation of the brain's capacity to acctnnUlate both norepinephrine injected
!into the cerebral ventricles and serotonin synthesized from the exogenously
I

iadministered precursor 5-hydroxytryptophan (Brodie et al., 1966).

I;findings
I

These

support the hypothesis that reserpine induced
sedation is related
.

'

lto imp~irment of the binding of monoamines, but the data do not allow

f separation

of the effects of catecholamine depletion from those of sero-

. tonin release or depletion.

However, relevant data come from studies in

1which the amino acid precursors of catecholamines and serotonin have been
!administered to animals previously given reserpine.

These precursor amino

Jacids, .unlike the monoamines, can cross the blood-brain barrier in animals

-~

i

!and raise the concentrations of the respective monoamines in the brain

I (Carlsson et al.,
I

1957).

Administration of dihydroxyphenylalanine, the

I catecholamine precursor, reverses reserpine-induced sedation in animals
{

f and restores gross behavior to approximately normal levels (Carlsson et al.,

:.;.,.,_ . . . . ,.-.

.

.

-~ --....-.-~.~-~ ~···"""l-----------------------·

I
•
!

---·-·---- . . . .--l
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,1963; Everett and Toman, 1959).

The serotonin precursor, 5-hydroxytrypto-

'

!phane, however, does not restore normal functioning (McGeer et al., 1963).
'

)These findings suggest the importance of catecholamine depletion in re-

•

.

I

~serpine-induced

sedation in animals, and possibly depression in man.

I

Based on the studies of Everett, Carlsson and others dopamine is now

I(merging

as an important neurotransmitter in its own right.

Previously

!dopamine was thought of primarily as a precursor to norepinephrine with

I

ilittle action of its own.

Dopamine in some cases is better correlated

'

lwith changes in behavior than norepinephrine (Creveling et al., 196.8).
'

jAlong this same line interest in dopamine as a neurotransmitter has been

!fostered by

H~rnykiewicz

(1966) who showed a deficit of dopamine in basal

ganglia of parkinson patients.
L-Dopa, the precursor to dopamine, is now widely used in the treatment
of parkinsons disease (Boullin and O'Brian, 1970).

When theorizing about

the possible function of neurotransmitters one nrust not talk of catechol-

1amines

in general but must distinguish between.the two amines, norepine-

phrine and dopamine.
A neurochemical theory, the catecholamine theory of mood, states

acts on norepinephrine levels only.

They include cocaine, amphetamines,

monoamine oxidase inhibitors, lithium, phenothiazines, and metabolic
~

inhibitors.

'-~··"_-'_«_,_____ '""~"'·'-·--mo -R·---·---------••
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However, as far back as 1914, research has verified that epinephrine
1or norepinephrine, when given so that it passes the blood-brain barrier

! (that

!

is, intraventricularly or intravenously into animals with inmature

iblood-brain barriers), produces a dose-response pattern of behavioral

\

.

(depression, lethargy, sleep, sedation, and stupor (Boss, 1914; Morinesca
'et al., 1929; Leimdorfer and Metzner, 1949; Sherwood and Richter, 1955;
Rothballer, 1959; Milhand and Glowinski, 1963; Brittain, 1966).

'l'hese

and other contradictory reports in both man and animals have lead to these
; conclusions: "At the present time, the neurophannacological psychochemical
research approach rests on insecure bases both in terms of the establishment of what are necessary and sufficient conditions in brain chemistry
to explain the metabolic effects of the drugs and in terms of the connection
of these changes with predictable behavioral phenomena" (Mandell and
Spooner, 1968) •
'l'he effects of amine levels generally are apparent only when the
!
~

levels are greatly changed.

I
I
j
Ii

Norepinephrine must be almost depleted before

the behavio}l'al effects of depletion are seen.

"The actual content of

I amines of the tissues is of only minor importance for the function"

Ji'

(Carlsson et al., 1963).

I

Behavioral states induced by drugs such as _L-dopa, phenethylamine,

5-hydroxy-tryptophane, and tryptamine have been all lumped as one "psy~

chosis" although obviously different to a careful observer (Randrup- and

I

Munkvad, 1966). Surely, if a direct correlation exists between levels of
i
Jbrain amines and behavior, the behavioral symptoms resulting from general

I

.

f accumulation of depletion of amines by different drugs should be similar.

t. . """" ., ______,_.. . . . . . . ,. . . . . . .,._.. ._.,.,~,¥'"~--------.u.-·----------·--------,··------'
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. This has generally not been the case, hOW"ever, based on the work done in
;this area.
In studies in which drugs are not employed, correlations have been
:found between amine and serotonin levels and emotion (Pryor et al., 1964),
;stereotypy and shock latencies (Scudder et al., 1968), and audiogenic
}

!seizures (Schlesinger et al., 1965).

I

Soote affective states in animals are accompanied by great alterations

lin the central catecholamines.

Welch and Welch (1965) found a lower brain

jnorepinephrine content in mice which were isolated than animals kept in

f aggregated groups of 25. Maynert and Levi (1968) found a 40% reduction
1.

>

jin brain norepinephrine concentration in rats following electrical shock

r to the feet.

1

f

Liberson (1964) reported a significant change in brain 5HT

l content

as a result of behavioral stress such as.fixation.

I;sensory

inputs such as those arising from

1

stre~s,

If external

shock, isolation and

1

I training

modifies amine levels, it might be expected that any drug which

f '

linduces internal change sensed by afferent nerves which record an animal's
'

:'.internal environmen.t might produce a change in· amine and serotonin levels

i
Jby the same mechanism.

The amine levels may not be a cause of behavior

I

!,but a result of a sensory stimulus.
!

The strength of drug effects on animal behavior varies depending on

I

I, the excitability of the central nervous system regardless of whether or

: not amines are affected by the drugs (Souskovi, 1964).

I
j

I

'

!
I
I

Barchas and Freedman (1963) found a fall in Brain NE levels

''and an equivalent rise in brain 5HT levels follOW"ing a swimming stress
I

{in rats.

.i

Furthermore, drugs

·.:affect specific behaviors in ways quite apart from simple changes in rates

!

l
I

13

..,
of task performances or amine level changes; in.other words, drug effects
are related to specific temporal sequences or responses and stinruli which

I
I

constitute behavior and over which amine levels may change in a nonspecific way (Kelleher et al., 1964).
As a result of recent advances in Radioactive tracer methodology the
rate of synthesis or so called "turnover rate" of catecholamines and serotonin has been determined (Costa and Neff, ·1969; Neff et al., 1969).

There

are various methods used to determine the "turnover rate" of catecholamines
and serotonin.

These include .!!! Vivo Studies and In Vitro Studies.

The

use of radioactive labeled precursors, 14c tyrosine and 14c tryptophane,
in in vitro and in ~ studies is based on the fact that 14c has a long
half life; 5720 years and that 14c will remain attached to the tyrosine
or tryptophane molecules as metabolism of the amino acids proceeds to the
products norepinephrine and serotonin respectively (Wang and Willis, 1966).
Thus a radioactive product is fonned which can be identified by means of
liquid scintillation (Costa and Neff, 1969).
atom attached to the monoamin~s.

~ 2 c is the normal carbon

The 14c can be attached biochemically

at various .carbon positions, e.g., C 1, 2, or can be uniformly attached
to the amino acid.

The attachment of the 14c does not interfer in any

way with the metabolism of tyrosine or tyrptophane nor does it interfer
with its function.

Although radioactive labelled precursors are expensive

'

they are readily obtainable and relatively safe to use.
The determination of "turnover rates" of catecholamines and serotonin has added some information as to the function of these biogenic

_ _ _ _ _ _ _ _ _ _ _ _JI

··-----------..----""'-""'__
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Recent studies have shown signifi-

housed animals; this finding suggested a decrease in brain serotonin
synthesis and inactivation for mice isolated over a prolonged period of
time.

It was suggested that the changes in brain serotonin metabolism may

in. this instance account for the behavioral differences found between
isolated and group-housed mice.

.
II
j

~

Tricyclic antidepressants are effective in the treatment of some

depressions, and it has been suggested that the clinical effects of these

drugs may be related to their effects on biogenic amines in the central

nervous· system.

Schildkraut et al. (1971) found the turnover of norepine-

phrine was decreased after acute administration of tricyclic antidepressants
but increased during chronic administration of these drugs.

This increase

in norepinephrine turnover occurred sooner when thyroxine was administered
with the antidepressant.

The suggestion was made that this may help to

explain why clinical antidepressant effects are generally observed only
after chronic administration of imipramine or protriptyline and why thyroid
hormone may accelerate and enhance the clinical antidepressant effects

15
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imipramine.
It seems true that metabolic paths relating to the amines are very

i labile

because almost any stress in the environment or internal millieu

I
'

t

causes fluctuations in the amines.

The purpose behind these experiments

Ii• to study the amines and behavior in an attempt to find a correlation
between the two, and to discuss a possible mechanism of action responsible
for the changes in behavior.

The research·was not intended to prove or

support a tight causal transmitter actuated behavioral mechanism, but it
can be seen from the above brief survey that there is a need for studies
on the relationships between amine and serotonin levels and behavior.
This research is extremely important both to clear the air of needless
suppositions and hypothesis and to provide a comprehensive ground plan to
guide further research.

I

In defense of the resulting conclusions the author

would like to quote the following:

"Even on a neurochemical level, we

.tIUst talk about emperica1 correlates rather than determinents of behaviora.l states.

Rigorous establishment of the transmitter or modulator

role of brain substances appears to remain for the future" (Mandel and
Spooner, 1968).

~-··
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Chapter II

!

MATERIALS and METHODS

Animals
All the animals used in these studies were male, 60 ± 10 day old,
ICR mice 'purchased from Scientific Small Animal Laboratory.

Prior to the

experiments the animals were housed for at least three weeks, fifteen to
a cage, in an environmental chamber at 75 degrees ± 5 degrees F with an
8 hour light cycle.

The animals were fed on Purina mouse pellets apd water

available ad lib idum.
Behavioral Test
The enviromnental situation was a "Mouse City" set-up made of plexiglass.

It is composed of six small home cages (5" x 7" x 4") each

connecting·with a central communal chamber (18" x ll" x 6") by means of a
. funnel-like, 12" x

l~"

cylindrical runway made of plastic tubing (Fig. 4).

Illumination was provided for all chambers by a diffuse overhead 40 watt
red light.

Sawdust was placed on the floor .of all the chambers, and food

pellets and water were provided in the central chamber.
In the city experiment, two aggregated males, which were naive to one
another, were weighed; the animals were marked with dye for the purposes
of identification, and after suitable drug pre-treatment one pair was
(

placed in each of the small "home" cages of the "city".

The experiment

proper was initiated fifteen minutes later, at which time cotton plugs
separating the "home" cages from the cOlllllUnal chamber were removed so that
the animals were free to interact.

At five minute intervals the behavior

.....----~--~------··~-~~~-----------------------------------------------~--_.
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the initial fifteen minute pre-experiment period).
minute checks per experiment per mouse
a distinct behavioral trait.

wer~

made, each corresponding to

Altogether, twenty "city" experiments, each

using naive mice, were conducted per drug group.
cities were also conducted.

Thus, fifteen five-

Twenty saline control

The mouse "city" experiments were run in the

afternoons between one and four o'clock.
The behaviors measured in the "city" were defined as follows:

Motor

movement from any one chamber to another, devoid of aggression and distinct
from·rapid flight, was recorded as exploration.

Any other motor activity

concerned, for instance, with fighting or gathering food, was not recorded
as explf?ration.
the sawdust.

Digging consisted of clawing at, piling up or re-arranging

Carrying things was defined as transportation of food pellets,

feces, sawdust, etc., from one point to another, whether or not it was
subsequently eaten.

Attack

(aggression) was defined as a movement toward

another animal accompanied by a bite.
if it was bitten:

An attack

leased the attacked.
often brief.)

An animal was listed as attacked .

was~recorded

as ended when the attacker re-

(The separation before renewal of an attack was

Sexual behavior was defined as mounting, accompanied by

19

~n ~ect
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of the enviromnent (e.g. repeated small jumps in one spot,

sommersaulting, running in circles, etc.).

l

In the act of freezing mice

became motionless and rigid; slight tremors were usually noticed and often
they "froze" in a semi-erect position, i.e., on their hind legs.

'11tis

behavioral trait could be readily differentiated from resting or sleeping;
it was generally, but not always, a response to a disturbance.

Sleeping

animals were usually found in a curled up position, their eyes were closed
and their breathing was slow, deep and regular.
any intake of food or water.

Ingestion was defined as

Self grooming and grooming other mice con-

sisted of the animal contacting gently with its mouth, tongue, teeth or
paws either its own body or that of another animal, respectively.
term being groomed is self explanatory.

'11te

Any unique or unusual trait

(e.g. catatonia) was also recorded at the five-minute check period.

I

Biochemical Determination

**

The measurement of the biogenic amines was by means of an Aminco

!Bowman Spectrophotoflurometer according to the technique of Wiegand and
Perry (1961).

Four pooled whole mouse brains were homogenized in two

volumes of 0.01 NHCL and extracted using four ml of homogenate, two gm
of NaCL and twenty-five ml n-heptane into four ml of 0.01 N HCL.

In each

extraction the tubes were.shaken at 250 counts/minutes for ten minutes.
Aliquots of 0.6 ml of this final acid extract were analyzed for norepinephrine and epinephrine using pH 5 and pH 3 buffer respectively.

I
t..

Fluorescence

A special thanks to Dr. Guy Everett from Abbott Laboratory for the
use of-,his lab, technician, and equipment while I was learning the
fundamentals of the biochemical techni ue.

I
I

I
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was measured in the spectrophotofluorometer at a wavelength of 397 mu
and 508 mu.
Of the acid extract 1.0 ml was placed on a water-washed Dowex
50 x 4 (200 - 400) mesh, Na-form colunm, 2 nm high and 5 mm wide.

sample was washed with a single application of 2 ml of water.

The

The dopa

was eluted in one tube with 8 ml of 0.025 M sodi\Dll phosphate buffer pH
6.5, and the dopamine was eluted in a second tube with 8 ml of the same
buffer containing 1 M<Cl.

Because fluorescent intensity developed slowly

in these samples unless they were irradiated fluorescence was determined
22 hours later at activation and fluorescent wavelengths of 334 nu and
380 mu respectively.
The remainder of the acid extract was used for the analysis of
serotonin by measuring fluorescence of the extract directly at the wavelengths.of 300 mu and 342 mu.

An acid blank and standard solutions of

dopa, dopamine, norepinephrine, epinephrine and serotonin were subjected
to the same manipulations as the samples.

· lbus, during one determination the brain levels of dopa, dopamine,
norepinephrine, epinephrine and serotonin were analyzed.

The concentrations

of the biogenic amines and serotonin are given as..ug/gm wet weight in
Table II, and as percent change from control in subsequent experiments.
Recovery experiments were conducted prior to the present set of
(

experiments; 90% of the norepinephrine, 71% of the dopa and 75% of the
dopamine standard added to control aliquots were recovered.
75% of the serotonin was recovered.

Approximately

Since these readings were constant

over a series of experiments and since the concentrations in brain are

21

given as percent change from control brain values, recovery experiments
were not conducted with each determination.

However, a saline control

was conducted with each set of experiments, and the values for the amines
were almost identical in this case.
The mice used for the biochemical determinations were taken from the
"mouse city" at the mid point of a regular "city" experiment (i.e., 35
minutes after the initiation of the experiment).
were not recorded for these experiments.

Behavioral determinations

The levels of amines of the

sacrificed mice were presumed parallel to those of the mice which were
kept for a complete "city" run and whose behavior was quantitated.

The

animals used for the biochemical determinations were taken from the
environmental (city) situation to eliminate any variable due to possible
effect~

of this enviromnent on biogenic amines and serotonin (cf. intro-

duction).

Although the behavior of the sacrificed mice piror to their

deaths was not recorded, it was judged similar in all ways to the corresponding.control or drugged "city" mice.
Drugs
All drugs were made up in saline and administered i.p., in a 0.01
ml/gm of mouse weight volume.
Two mg/cc of tragecanth were added to suspend (CPlO) parachlorophenylalanine and "-MPT) alpha-methyl-paratyrosine in saline.
abbreviations are used in this paper as follows:

Certain

l
I

I
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CNS = central nervous system
NE = norepinephrine

E
~MPT

= epinephrine
=methyl-para-tyrosine

CplO

= parachlorophenylalanine

MADI

= mono-amine

oxidase inhibitor

5HTP = 5-hydroxy tryptophane
5HT = (serotonin) 5-hydroxy trypt amine
L-DOPA = dihydroxyphenylalanine
IlA = dopamine

Mechanism of Action of Drugs Used
(Fig. 3)
J..-methyl-para-tyrosirie ( MPr)
~MPT

inhibits the enzymatic formation of Dopa from tyrosine.

Speci-

of tyrosine hydroxylase and as such re(Moore, 196 7).

Since

~MPr

does not

affect brain 5HT ievels, this agent is a valuable tool for investigating
the significance of catecholamines in the central nervous system
(Spector et al., 1965).
This drug has been extensively used as a pharmacological tool for the
investigation of brain catecholamines (Moore, 1%8; Rech et al., 1966;
Levitt et al., 1965).
Pargyline (M0-911)

I
.

'

The enzyme monoamine oxidase is responsible for the degradation of the
l

J
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DRUG

DOS AGE

Pargyli ne (M0-911)

100 mg/kg

Mech

MAO

of

Act

In hi b 1 t or
i
1:

L- Dopa

50mg/kg

NE

Precursor

Is
':~

i;
~;

I.
5-Hydroxyt ryptop ha n e
( 5- HT P)
o-methyl-p-tyrosine
(Ol-MPT)

I

P-chlorophenylalanine
( CP-10)

IOOmg/Kq

80 mg/kg

· 3!6m9/kg

I

5HT

Precursor

Tyrosine Hydroxy lase
Inhibitor
5HT
Synthesis
Inhibitor

I
Fig. 3
Drugs, Dosage and Mechanism of Action
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II

catecholamines and serotonin.

This enzyme, along with catechol a-methyl

l

f transferase (COMT) plays a key role in controlling the amounts of NE,

f 5HT and DA stored in the brain (Spector et al., 1960).
f

Pargyline inhibits

the enzyme monoamine oxidase so that its administration leads to a marked
increase of endogenous amines and serotonin (Shore and Olen, 1958;
Spector et al., 1960; Quastel, 1965; Wiegand and Perry, 1961).
(P-chlorophenylalanine) (CP-10)
P-chlorophenylalanine blocks the synthesis of SHT in the brain without affecting other amines such as norepinephrine or dopamine (Koe and
Weissman, 1966).
P-chlorophenylalanine inhibits liver tryptophane hydroxylase in vitro
and strongly suppresses the tryptophan and phenylalanine hydroxylating
capacities of liver treated with it (Koe and Weissman, 1966).

These

results suggest that P-chlorophenylalanine may effect 5HT depletion by
inhibiting the biosynthesis of this monoamine probably by blocking tyrpto-

f

lphan

hy~roxylation.

It has also been suggesteq that CplO may interfere with

uptake of the precursor 5HTP (Pletscher et al., 1963; Pletcher et al., 1964).
(5-hydroxytryptophane) - SHTP
SHTP is the immediate precursor of 5HT in the biosynthetic pathway
of this monoamine.

Injection

of

SHTP will increase the amounts of 5HT

!in brain tissue (Undenfriend et a;., 1956).
L-Dopa
Dopa is the precursor to dopamine, norepinephrine and epinephrine in
the biosynthetic pathways of these biogenic amines.

I

Injection of L-Dopa

will increase the levels of these substances in brain tissue (Wiegand and
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!perry, 1961; Guroff et al., 1961; Yoshida et al., 1963).

Nonspecific de-

!
jcarboxylation by which dopamine is formed from dopa occurs throughout the
i

ibrain and the regional distribution of the decarboxylases generally follows
fthat of catecholamines (Bertles and Rosengren, 1959).

i

L._ __________________________
i
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Chapter III

!

EXPERIMENTAL DESIGN

I

I
I

The purpose of this experiment was to administer drugs which would

selectively raise or lower the levels of the catecholamines and/or serotonin while carefully noting the behavioral results.

On

the basis of

the literature and previous pilot runs, dosages were used which were
found not fatal to the mice.

11le control "city" study (Exp. I) represents

an average of 20 "city" experiments.
between consecutive similar runs.

11lere was no appreciable difference

An occasional hyperactive, aggressive,

or sleepy mouse did not appreciably change the average number of counts
per "city" experiment from one experiment to another in the controls or
drug experiments.

11le behavior of the animals is given for each experi-

ment as a numerical index (average number of checks per experiment per
mouse).

Table I lists experimental numbers, the drugs used and the

number of "mouse city'; runs and animals used in· each experiment.

i

I
i

I
I

II

I

'_ _ __J

TABLE I
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EXPERil1ENT NO.

NO. OF "MOUSE CITIES"

DRUG

NO. OF ANIMALS
PER

x

c ITY"

~A.-Methyl-p-tyrosine

80 mg/kg
5-hydroxy-tryptophane
100 mg/kg

XI

II

20

12

20

12

20

12

-Parachlorophenylalanine
316 mg/kg

20

12

-Parachlorophenylalanine
316 mg/kg .
ol---Methyl-p-tyrosine
80 mg/kg

20

12

-Parachlorophenylalanine
316 mg/kg
Pargyline 100 mg/kg
5-hydroxytryptophane
100 mg/kg
ot..-Methyl-p-tyrosine
80 mg/kg

20

12

Pargyline 100 mg/kg
~-Methyl-p-tyrosine

80 mg/kg
L-Dopa 50 mg/kg

XII

XIII
XIV

xv

«--Methyl-p-tyrosine
80 mg/kg
L-Dopa 50 mg/kg

UBLE I

r
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Evaluation of Data
The biogenic amine data was analyzed for significance using an un-

)

I

lpaired student-t-test comparing each experiment with the control.

The

!

!higher variance among animals receiving drugs is possibly due to added

I

~

isources of error.

The rate of absorption of the drug, and the rate of

synthesis of catecholamines and serotonin may vary from animal to animal,
but the results were sufficiently consistent to permit a significant
. statistic.
The data from "mouse city" are presented as the average behavioral

experimental situation.
.average

se~al

Occasionally a homosexual mouse may give the

behavior a high number, but the standard deviation is also

\
jhigh.

Those behaviors however which are shown by all animals during every

I

iexperiment, e.g. exploration, provide satisfactory data for statistical

I
;

.

Ianalysis.

Generally with such data the standard deviation ranges to about

110% of the control values (Scudder et,al., 1969).

With the introduction

lof drugs into the experiment, new behaviors occur sporadically, replacing

f the usual behaviors.

The new behaviors are obviously significant and these

jas well as the orderly decreases

~nd

increases seen in the frequencies of

i

!the more usual behavioral acts are the main variables of such experiments,
the data are presented here with confidence that similar trends would occur
on further replication of the experiments.

I

I
i

~'Ol

The results of the biogenic amine analysis are given in Table II.
...• · - - - - - - - - - - -
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;A total of 15 separate determinations were run per each experiment.
!Not nruch importance can be attached to the epinephrine levels as the
!measurement of this amine is at the limit of the technique.

Enormous

f differences were encountered between treatment groups as to the levels of
!catecholamines and serotonin.

These changes

wer~

in agreement with the

specific drug effects expected on the basis of information provided by
the literature and presented in the above

e~perimental

design section.

Thus a monoamine oxidase (MAO) inhibitor, (Pargyline) followed by a
serotonin precursor, «5-hydroxytryptophane) (5HTP), gave a large seiotonin (5HT) increase.

Similarly Pargyline (MAO!) followed by a NE pre-

cursor, L-Dopa, gave a large increase in dopamine and NE.
NE, <l.MPT), removed selectively almost all of the NE.

A depleter of

A serotonin de-

pleter (CP-10) removed almost all serotonin selectively in some of the
experiments.

Biochemical results of drug combinations were difficult to

predict as stated in the experimental design.

It.was in these cases of

less commonly studied drug combinations that amine levels and behavior

I

I

I

I
I
I

are probably not causally related was substantiated.
It is not easy to present a reader with the many correlations which
such data allows.

To lessen confusion and augment reading, each experi-

ment involving either a control situation or a specific drug treatment
is discussed separately in the order below and a general discussion of
the entire picture stressing correlative similarities or relationships
will follow (Chapter V).

'

i

I
I

I

l
I
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Chapter IV
RESULTS

Table II represents the levels of DA, NE and SHT found in whole

'

!mouse brain before and after drug treatment.

i

Jpressed in..ug/gm wet± SE weight.

'

jgroup.

'

I

The levels here are ex-

Experiment I is the saline control

32
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5HT

DA

NE

.875 ± .018

.465 ± .021

.650 ± .060

II

1.330 ± .168

.628 ± .010

.566 ± .016

III

1. 986 ± .185

.604 ± .010

1.822 ± .165

IV

4.573 ± .210

1.023 ± .019

2.762 ± .142

.910 ± .019

.452 ± .016

1.462 ± .100

1.967 ± .103

.797 ± .021·

3.812 ± .169

VII

.010 ± .012

.010 ± .010

.699 ± .142

VIII

.657 ± .016

.317 ± .018

3.170 ± .201

IX

• 744 ± .050

.303 ± .012

3.650 ± .198

x

.014 ± .010

.050 ± .014

2.080 ± .019

1.050 ± .260

.744 ± .126

2.600 ± .169

XII

.700 ± .198

.349 ± .010

.663 ± .101

XIII

.832 ± .091

.469 ± .025

.260 ± .014

XIV

.009 ± .012

.028 ± .065

.260 ± .016

xv

.041 ± .086

;009 ± .014

2.110 ± .162

EXPERIMENT

I

v
. VI

XI

TABLE II

r

f
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Experiment I

In an average saline control "city" experiment the animals showed

f the following behaviors:
I

TRAIT

NUMERICAL INDEX
Average uumbet of checks per
experiment per mouse ± Sd.

-Exploring

7.0 ± .8

Digging

0.3 ± .3

Stereotypic Behavior

0.1 ± .1

Sleeping

2.0 ± .1

Freezing

0.1 ± .2

Cont actual Behavior

0.1 ± .1

Ingestion

0.5 ± .3

Sexual Behavior

0.0

Grooming Se 1f

2.0 ± .2

Being Groomed

0.2 ± .2

Grooming Other

0.5 ± .3

Aggression

1.5 ± .4

t:hart 1

I
t
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Experiment I

I
I

I

These data represents averages from 20 "city" experiments in which the

;animals were injected with saline.

Saline administration has, of course,

a slight depressant action (Meier and Huff, 1962).

I

If the pre-treatment (housing and nature of aggregation) of the mice

is carefully standardized the behavior of tbe animals in the "city" is

quite constant.

Occasionally a very aggressive, homosexual, or stero-

typic animal is encountered.
All subsequent behavioral experiments of this study were compared
with these mean control values.

Generally, mice have high values for

exploration and low values for other traits.
C~rtain

other abnormal behaviors e.g. writhing, paralysis, and

catatonia appear in drugged mice and are not entered on this chart

I

(Chart 1).

i

I
i

I
~

j__.._,_________________________
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Experiment I I

DOSAGES AND DRUGS
j

l·
L-Dopa 50 mg/kg
L-Dopa 15 minutes before experiment

AMINE

BIOGENIC AMINE LEVELS
% CHANGE FROM CONTROL

DA

+ 55 p<.01

NE

+ 35 p<.01

E

+ 5 not sig.

5HT

- 3 not sig.

Chart 2

r
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Experiment II

COMPARISON WITH CONTROL "CITY EXPERIMENTS

I
;

NUMERICAL INDEX

TRAIT

I

CONTROL

DRUGGED

Exploration decreased

7.0 ± .8

0.5 ± .3

Digging decreased

0.3 : .3

o.o

Stereotypic Behavior decreased

0.1 ± .1

o.o

Sleeping increased

2.0 ± .1

2.5 ± .4

Freezing decreased

0.1 ± .2

0.0

Contactual Behavior increased

0.1 ± .1

0.4 ± .4

0.5 ± .3

o.o

o.o

0.0

2:0 ± .2

1.0 ± .2

'0.2 ± .2

0.0

Grooming Other decreased

0.5 ± .3

o.o

Aggression decreased

1.5 ± ;4

o.o

Catatonia increased

0.0

·Ingestion decreased
Sexual Behavior stayed the same

f Grooming Self decreased
Being

G~oomed

decreased

10.0 ± .2

Chart 2a

I
I

1-·~,-------------------------------------
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Experiment II

!

For the first hour of the experiment the animals were in a catatonic
state.
tail.

They held their tails erect and rigid, resembling a "Straub"
The mice were seemingly not aware of each other or of their environ-

i

lment.

The animals upon being_placed in the "city" would asswne a rigid

iposition and hold it no matter how awkward ·the position

appeared~

After

(the first hour the mice relaxed to a resting-sleeping position, never

I going through the excited exploratory phase usually seen when an animal
is placed in a novel environment.
physical appearance.

Nothing unusual was noticed in their

Body temperature was normal {42 degrees C) for

this strain.
Since there has been a s'light 5HT decrease a large DA and NE increase
lin these animals, the amine changes may, presumably, be correlated with
i

ithe catatonia and depression.

Some authors have·considered a change in

j

jsleeping time to relate to an increase SHT line (Jouriet, 1969).

il possible causal effects of

th~

The

amines and serotonin on the behavioral

Ieffects seen in this experiment will be discussed later

(general dis-

cuss ion).

___ J
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Experiment III

DOSAGES AND DRUGS

Pargyline 100 mg/kg
Pargyline

24 hours before experiment
Biogenic Amine levels

% change from controls
DA.

+ 127

P.<.Ol

N

+ 30

p .<. 01

E

- 3

not sig.

5HT

+ 222

P.2.01

~Chart

~

·--
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Experiment III
i
~

'

COMPARISON WITII CONTROL "CITY" EXPERiliENTS

i

I

ITRAIT

NUMERICAL INDEX

,

1-

~

CONTROL

DRUGGED

iExploration stayed the same

7.0 ± .8

6.5 ± .5

f Digging stayed the same

0.3 ± .3

0.2 ± .2

f stereotYJ?ic Behavior stayed the same

0.1 ± .1

o·.1 ± .1

'Sleeping decreased

2.0 ± .1

1.5 ± .2

iFreezing stayed the same

0.1 ± .2

0.1 ± .1

jcontactual Behavior stayed the same

0.1 ± .1

0.1 ± .2

r Ingest~on st.ayed the s~e

0.5 ± .3

0.4 ± .3

jsexual Behavior stayed the same

0.0

o.o

2.0 ± .2

1.8 ± .5

0.2 ± .2

0.2 ± .2

0.5 ± .3

0.4 ± .1

1.5 ± .4

1.0 ± .6

i
~

·~

~

I

Grooming Se 1f decreased

--

t Being

·

~o_omed stayed the same

Grooming Other decreased

!

(Aggression decreased

I
Chart 3a

t

f
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Experiment III

There was no significant behavioral diffe:rence between this "city"
and a normal control saline injected "city" run.
The increases in NE, 5HT and DA were without effect behaviorally.
f These changes in amines are in excess of those changes seen when L-dopa
1

'

alone was administered (Exp. II) and catatonia was seen.

.

!observed in these pargyline treated mice.

No catatonia was

Pargyline although a more

;profoundly ami:ne modulating drug than dopa, did not affect behavior ·as
'did L-dopa alone.

It was expected that the animals might show an increase

in activity and irritability described by Everett (1961), but they did
not even though the total amine level was doubled as compared to control.
It was also expected that the animals might show an increase in sterotypic behavior described by Randrup and Munkvad (1966) for rats; however,

f this

was not the case.

I
I

I
f
L

__ J
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Experiment IV

DOSAGE AND DRUGS

Pargyline 100 mg/kg, L-Dopa 50 mg/kg
Pargyline, one day before experiment, L-Dopa,
15 minutes before experiment.

BIOGENIC AMINE LEVELS
% CHANGE FR<»! C~OLS
,,

M

+ 425

p<.01

NE

+ 120

p<.01

E

+3

not sig.

5BT

+ 325

p<.01
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Experiment IV

CCMPARISON WITH CONTROL °CITY'' EXPERIMENTS
.
.

NUMERICAL INDEX

IBAll

CONTROL

DRUGGED

Exploration decreased

7.0

:I:

.8

. 1.0

:I:

.3

Digging stayed the same

0.3

:I:

.3

0.3

:I:

.4

Stereotxpic Behavior decreased

0.1

:I:

.1

o~o

Sleeping increased

2.0

:I:

.1

4.0

:I:

.4

Freezing remained the same

0.1

:I:

.2

0.1

:I:

.1

Contactual Behavior decreased

0.1

:I:

.1

0.1

:I:

.1

Ingestion decreased

0.5

:I:

.3

0.0

.S.exual Behavior remained the same

0.0

Grooming Self decreased

2.0

:I:

.2

0.5

:I:

.2

Being Groomed decreased

0.5

:I:

.2

.Aggression decreased

1.5

:I:

.4

o.o
o.o

Catatonia increased

o.o

:I:

.3

Chart 4a
~

o.o

9.0
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Experiment IV

For the first hour of the "city" experiment the mice were in a
catatonic state similar to the mice described in Exp. II, after which
they returned to a resting-sleeping position.
This effect has been presumed to be due to increase in norepinephrine
and dopamine and is a "classic" experiment .often reported in the. literature
(Wiegand and Perry, 1961).

There was an increase in 5HT and NE; greater

than that seen .after either drug alone, and a large increase in DA:

In

the "city" environment without close packing of the mice and subsequent
aggregate effects, the excitement and irritability seen by others after
pargyline and L-dopa administration was absent.

This suggests that the

environment may interact with the animals drugged condition to produce
differential behavioral effects.
The main behavioral effect seen in this
like depression.

exp~riment

was a catatonic-

This effect may be considered to be a direct effect of

the drug, L-Dopa on the CNS.
amines need be involved per

There seems to be no proof that the
_!!

in this catatonia for catatonia was not

found in subsequent experiments when dopa was not employed yet amine
levels were similar.

This relationship will be further discussed in a

following chapter (Chapter V).

r
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EXperiment V

i

DOSAGES AND DRUGS

5HTP 100 mg/kg
5HTP 100 mg/kg

15 minutes before experiment

Biogenic Amine Levels
DA

+4

not sig.

NE

3

not sig.

E

- 4

not sig.

5HT

+ 125

P.<.01

Chart 5
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Experiment V

C<MPARISON WITH CONTROL "CITY'' EXPERlMENTS

NUMERICAL INDEX

TRIAT

CONTROL

DRUGGED

. 7.0 ± .8

6.0 ± .5

Digging stayed the same

0.3 :l: .3

0.4 ± .3

StereotyPic stayed the same

0.1 ± .1

0.1 ± .1

Sleeping stayed the same

2.0 ± .1

2.0 ± .2

Freezing stayed the same

0.1 ± .2

0.1 ± .1

Contactual stayed the same

0.1 ± .1

0.1 ± .1

Ingestion stayed the same

0.5 ± .3

0.4 ± .1

Sexual Behavior stayed the same

0.0

o.o

Grooming Self stayed the same

2.0

.2

1.6 ± .5

Being Groomed stayed the same

0.2 ± .2

0.1 ± .1

Grooming Others stayed the same

0.5 ± .3

0.4 ± .2

Aggression stayed the same

1.5 ± .4

1.0 ± .6

EXJ>loring stayed the same

'.·:,
,._,
{'
~

Chart Sa
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Experiment V

The behavior of the animals receiving SHTP was in no way different
from the behavior of the saline treated control animals.

Joyce and

~

Mrosovsky (1964) found a significant decrease in food and an increase in

1
~

water intake, and a motor retardation in rats receiving SHTP.

•

It was

expected, therefore, that in the present experiment a change in ingestion
might be seen.

This was not the case, however.

Nor was any motor im-

pairment seen in this experiment as reported often in the literature
(Joyce and Hurtwitz, 1964).

The changes in behavior found by Joyce and

co-workers will be further discussed in the following section (Exp. VI
and Chapter V) .

r
f

~·

~
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Experiment VI

Pargyline 100 mg/kg

5HTP 100 mg/kg

Pargyline - 24 hours before experiment:

5HTP 15 minutes

before experiment

Biogenic Amine Levels
% change from controls
~" '

DA

+ 126

P.<.01

NE

+ 50

P.<.01

0

E

+ 425

5HTP

Chart 6

P.<.01

I
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Experiment VI

COMPARISON WITH CONTROL "CITY'' EXPERIMENTS

NUMERICAL INDEX

Exploration decreased

CONTROL

DRUGGED

. 7.0 ± .8

2.0 ± .2

Digging decreased

0.3 :Ir .3

Stereot;ypic Behavior decreased

0.1 ± .1

o.o
o.o

Sleeping decreased

2.0 ± .1

0.0

Freezing decreased

0.1 ± .2

0.0

Contactual Behavior decreased

0.1 ± .1

o.o

Ingestion decreased

0.5 ± .3

0.0

Sexual Behavior stayed the same

o.o

o.o

Grooming Self decreased

2.0 :E: .2

0.0

~

0.2 ± .2

0.0

Grooming Other decreased

0.5 ± .3

Aggression decreased

1.5 ± .4

o.o
o.o

Paralysis

o.o

I
I'

Groomed decreased

Chart 6a

15.0 ± .1
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Experiment VI

I

iI

All animals seemed paralyzed in the hind limbs and this led to an

almost complete behavioral deficit.

'11leir forelimbs and hindlimbs were

abducted in a "spread eagle" fashion.
of the experiment.

'11le animals were tranquil for most

During the last fifteen minutes of the experiment the

animals assumed a resting position.

'11lree .(3) of the animals had slight

respiratory problems characterized by hacking and irregular breathing.
The animals seemed normal until the 5HTP injection.
'11le abduction or characteristic posture assumed by 5HTP treated mice
may be due to
./

t~e

large serotonin increase which is the notable effect of

this drug treatment although admittedly DA and NE increased also.

'11lis

increase was less than that of previous experiments and cannot be held
accountable. for the unusual neuromuscular deficit.

"Spread eagle" abduction

has been reported to occur in animals after 5HTP _with or without pargyline
pretreatment (Everett, 1959).

As described in _Exp. V, motor deficit was

the basis for the effect of 5HTP on avoidance behavior in rats (Joyce and
Hurtwitz, 1964).

Joyce and Mrosovsky (1964) reported increased drinking

associated with high central levels of 5HT in mice.

We saw no such

behavioral change, in fact injestion decreased in our experiments.
Joyce suggested many factors, from osmoreceptor effects to emotionality
~

changes, to account for the increased water consumption.

Important is

her reference to Toman (1963) that the direct action of the amino acid
precursor, 5HTP, may be involved.

As was pointed out before, however, no

___________________________________________

I

neuromuscular deficit or motor impairment was seen in our experiments after __.
..._

50
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jSHTP was administered alone (Exp. V).
This paralysis seen in this experiment will be discussed in a further
(Chapter V) .

/
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Experiment VII

!
i

t

DOSAGES AND DRUGS

,,

~

L

r

"'
'~

cJ. MPT 80 mg/kg

J..MPT:

TID q 4 hours for one day, and one hour before the

experiment.

- 99

P.<.01

NE

- 98

P.<.Ol

E

- 6

not sig.

5HT

+

not sig.

3

Chart 7
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Experiment VII

}

COMPARISON WITH CONTROL "CITY'' EXPERIMENTS

i TRAIT

NUMERICAL INDEX
CONTROL

DRUGGED

Exploration decreased

·7.0 ± .8

2.0 ± .6

Digging decreased

0.3 ± .3

0.2 ± .1

Stereotypic Behavior decreased

0.1 ± .1

0.0

Sleeping increased

2.0 ± .1

10.0 ± .4

Freezing stayed the same

0.1 ± .2

0.1 ± .1

Contactual Behavior increased

0.1 ± .1

2.0 ± .4

Ingestion stayed the same

0.5 ± .3

0.4 ± .5

Sexual Behavior stayed the same

0.0

o.o

Grooming Self decreased

2.0 ±·.2

1.6 ± .5

Being Groomed. stayed the same

0.2-± .2

0.2 ± .3

Grooming Other decrea.sed

0.5 ± .3

0.3 ± .1

Aggression decreased

1.5 ± .4

o.o

I

~hart

I
I

7a
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Experiment VII

I

All of the animals were depressed and most slept throughout the

!experiment.

I!minutes

I

Piloerection was noticed during the first fifteen (15)

of the experiment occurring in 50% of the animals.

was noticed, however.

ventrally.
degrees C).

No trembling

llhen placed in the "city" the animals were wet

Body temperature, however, was normal for this strain (42
A viscous substance appeared around the genitalia.

These animals had suffered a considerable loss of NE and DA.

They

were depressed, sleeping was tnuch increased as was contactual behavior.
We thought that perhaps the low NE and DA level was causally related to
the behavioral depression.

A direct relationship between low NE and sleep

is the·only consistant one from the data presented so far.

Spector et al.

(1965), Moore (1967,_ 1968) and Hanson (1965) reported thatµ.n>T produces
overt sedation and depression of conditioned behavioral responses.

I

Weissman and Koe (1965), however, suggested that the depressant effects of

~MPT

were secondary to the toxicity of the drug.

using multiple i.p. injections of

~MPT

Rech et al. (1966)

found that the drug caused impaired

avoidance responding, retarded performance and spontaneous locomotor
activity without producing obvious toxic effects.

The content of J..MPT in

~

the brain and depletion of brain norepinephrine and dopamine both exhibited
a time course similar to that of the behavioral depression.

Moore (1968)

found a depression in avoidance conditioning of guinea pigs following

J.MPT administration and related the depression to the early CA depleting

l----------~-----------------------------------'
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Ii effects .,,..MPT.
I
l

The depression and sleep seen in this experiment will be discussed

lin a following section with regard to the causal effects of NE and DA on
the behavioral effects seen (Chapter V).

I.__
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Experiment VIII

!Pargyline

100 mg/kg. 1J-.MPT 80 mg/kg.

TID

q

Pargyline 24 hours before experiment.

4 hours for one day and one hour before
experiment.
.
)

BiQgenic Amine Levels
% change from controls
M

- 25

p .<.01

NE

- 32

P.<.01

E

- 2

not sig.

5HT

+ 380

P.<.001

Chart 8

r
56
{-'~

......,,

___

I ••1:. -

• - - - - __ ,Vri ...~·--------------.-.--•",;-··----~------·--,

I

l
~

Experiment VIII

CCMPARISON WITH CONTROL "CITY'' EXPERD1ENTS

Chart 8a

r
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Experiment VIII

All animals appeared as normal control animals.
!

!noticed in their appearance.

l

I

f for

Nothing unusual was

Body temperature was normal (42 degrees C)

this strain.
The Pargyline apparently counteracts the.1-MPT sleep producing effects

!observed in Exp. VII.
depletion of NE and DA..

Concurrently it prevented to a certain extent a
Presumably the

sedation~

contactual behavior,

and secretions seen in the previous study are due either to a very low
NE or DA levels or a blockade of the direct toxic action of
pargaline.

~MPT

by

The increase in 5HT by pargeline was seen previously (Exp. III)

and is without behavioral effect.

58

Experiment IX

DOSAGES AND DRUGS

Pargyline 100 mg/kg, J..MPT 80 mg/kg, 5HTP 100 mg/kg.
rargyline 24 hours before experiment.

MPT TIO q 4

hours for one day and one hour before experiment ..

SHPT 15 minutes before experiment.

BIOGENIC AMINE LEVELS
% CHANGE FRCM CONTROL
DA

- 15

P.<.01

NE

- 35

p .<. 01

E

- 2

not sig.

5HT

+ 400

P.<.001

Chart 9
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Experiment IX

I
'

COMPARISON WITH CONTROL "CITY'' EXPERIMENTS

TRAITS

NUMERICAL INDEX
COOTROL

DRUGGED

Exploration decreased

1.0 ± .8

o.o

Digging dee reased

0.3 ± .3

0.0

Stereotypic Behavior decreased

0.1 ± .1

o.o

Sleeping de creased

2.0 ± .1

0.0

Freezing de creased

0.1 ± .2

0.0

Contactual Behavior decreased

0.1 ± .1

decreased

0.5 ± .3

o.o
o.o

Ingesti~

·o.o

Sexual Behavior stayed the same

0.0

Grooming·se
_!!: decreased

2.0 ± ·.2

o.o

~Gro omed

0.5

.2

o.o

Grooming Other decreased

0.5 ± .3

0.0

Aggression decreased

1.5 ± .4

0.0

Paralysis i ncreased

0.0

decreased

Chart 9a

L

d:

15.0 ± .3
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Experiment .!!

All animals were extensively paralyzed.
behavioral deficit.
eagle" fashion.

This resulted in a complete

_

Both forelimbs and hindlimba were abducted in-. "apread
...

All animals seemed --..
irritable
excited.
...................... and ......................

There appeared

quick, jerky movements of the head, accompanied by constant sniffing of the
~·

ground.

~

to rotate on their hindlimbs.

l

Piloerection was noticed in two - (~) ani•la.

The animals seemed

All animals had respiratory pYoblema
I

~

characterized by hacking and irregular respiration.
•?-

averaged 1 degree below normal.

Body temperature

The paralysis seen in this experiment

was much more severe than that seen in Exp. VI.
The animals appeared normal before the injection of 5HTP,
'

were decreased but 5HT was much increased.

NE and DA

The behavioral effect may be

preslimed due to the 5HT increase - yet this increase was less than the 5HT
level reached by an injection of 5HTP and pargyline together: (Exp. VI}.
No mnine of 5HT level is therefore a really

s~nd

explanation for this

toxicity in that different drugs (discussed in Chapter V) produced similar
levels of amines and 5HT without such a toxic or behavioral syndrome.
Since the neuromuscular deficit was so great, a potentiation of direct
5HTP toxicity seems the most logical explanation because the 5HT level
causing this pronounced paralysis is less than that causing a paralysis
~

which was not quite so severe.

On the other hand, perhaps the combination

of a quite high level of serotonin with suitable changes in the other amine
levels may account for the effect seen.

In this experiment the pronounced

r
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excitation occurred when both NE and DA were low.

Such an effect would

not be expected if low NE caused sedation as discussed in Exp. VII and VIII.
This indicates that brain NE levels are not a reliable index of excitement
as was postulated previously in this series of experiments unless, of
I.

course, the high 5HT counteracted the sedating effect of law NE and DA.
The paralysis seen in this experiment will be discussed in a following
section (Chapter V).

r
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Experiment X

DOSAGE AND DRUGS

~MPT

.>-MPT:

80 mg/kg.

5HTP 100 mg/kg

TID q 4 hours for one day and one boor before experiment.

5HTP 15 minutes before experiment.

Biogenic Amine Levels
'7. change from controls

DA

- 95

P.<.01

NE

- 85

P.<.01

E

- 2

not sig.

5HT

+ 220

P.<.01

Chart 10

I
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Experiment X

CCl1PARISON WITH CONTROL "CITY" EXPERIMENTS

IRA ITS

NUMERICAL INDEX
CONTROL

DRUGGED

Exploration decreased

7,0 ± .8

4.0 ± .3

Digging stayed the same

0.3 ± .3

0.2 ± .1

Stereot:rpic Behavior stayed the same

0.1 ± .1

0.1 ± .1

Sleeping increased

2.0 ± .1

4.0 ± .4

Freezing stayed the same

0.1 ± .1

0.1 ± .1

Contactual Behavior increased

0.1 ± .2

1.0 ± .5

Ingestion decreased

0.5 ± .3

0.4 ± .1

Sexual Behavior stayed the same

o.o

0.0

Grooming Self decreased

2.0 ± •.2

o.o

Being Groomed decreased

0.2 ±. .2

0.0

Grooming Other decreased

0.5 ± .3

o.o

Aggression decreased

1.5 ± .4

0.0

Chart lOa
~
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l
Experiment

~

All of the animals were very tranquil and quiet during this series
of experiments.

'l11.ey assumed a resting-sleeping position throughout most

of the "city" runs.

'11te animals were not different from control mice ex-

cept for the .-..MPT effect described earlier; (writhing, ventral wetting and
depression). . No ataxia was observed during. the ·"city" study.
Biochemically, 5HT was increased and all amines decreased.

'l11.e animals

slept for most of the experiment and behaved similar to those animals
givenJ...MPT alone (Exp. VII) although sleeping was less in this series.
'l11.e sleeping behavior seen in this experiment will be discussed in
Chapter V.
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Experiment XI

Pargyline 100 mg/kg, J.-MPI' 80 mg/kg.

L-Dopa 50 mg/kg.

Pargyline 25 hours before experiment.
J....MPI'

TID q 4 hours for one day and one hour before experiment.

L-Dopa 15 minutes before experiment

Biogenic Amine Levels

% change from control
..

i,

DA

+ 20

P.<.01

NE

+ 60

P.<.01

E

+ 2

not sig.

5HT

+ 300

P.<.01

Chart 11

r
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Experiment XI

CCMPARISON WI'lll CONTROL "CITY" EXPERIMENTS

TRAITS

NUMERICAL INDEX
CCl!ITR.OL

DRUGGED

Exploration decreased

?.o

.a

1.0 ± .4

Digging decreased

0.3 ± .3

0.2 ± .1

StereotyPic Behavior decreased

0.1 ± .1

0.0

Sleeping decreased

2.0 ± .1

o.o

Freezing decreased

0.1 ± .2

0.0

Contactual Behavior decreased

0.1 ± .1

. 0.0

Ingestion decreased

0.5 ± .3

o.o

Sexual Behavior decreased

o.o

0.0

Grooming §.£!!

decreas~d

2.0 ± :2

0.0

Being Groomed decreased

0.2 :I: .2

o.o

Grooming other decreased

0.5 ± .3

0.0

Aggression decreased

1.5 ± .4

0.0

Catatonia increased

0.0

Chart lla

±

10.0 ± .3

I
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Experiment XI

All of the animals assumed a catatonic state after the injection of
L-Dopa and this accounts for the behavioral deficit.

When placed in the

"city" they would hold the position in which they were placed.

After the

first forty-five (45) minutes the animals began to walk and assume different
positions which they would then hold for long periods of time.
erection was noticed during the first fifteen (15) minutes.
ature was normal.

Pilo-

Body temper-

The animals moved slowly with no ataxia.

No amine in. this experiment exceeded levels which in other experiments were correlated with toxic effects.

However catatonia was observed.

Therefore the catatonia is possibly not due to amine levels but some other
direct action of L-Dopa on the CNS.

r
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Experiment XII

DOSAGE AND DRUGS

J.MP'f 80 mg/kg.

L-Dopa 50 mg/kg.

PT - TID q 4 hours for one day and one hour before experiment.
L-Dopa - 15 minutes before experiment.

Biogenic Amine Levels
% change from control
Ill\

- 20

p .<. 01

NE

25

P.<.01

E

- 6

not sig.

5HT

+2

not sig.

~

Chart 12
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Experiment XII

CCMPARISON WITH CONTROL "CITY" EXPERIMENTS

NUMERICAL INDEX

TRAIT

CONTROL

DRUGGED

Exploration decreased

7.0 :I: .8

1.0 ± .1

Digging decreased

0.3 ± .3

Stereot;ypic Behavior

0.1 ± .1

o.o
o.o

Sleeping increased

2.0 :I: .1

8.0 ± .3

Freezing decreased

0.1 ± .2

o.o

Contactual Behavior increased

0.1 ± .1

1.0 ± .2

!ngestion stayed the same

0.5 :I: .3

0.4 :I: .1

Sexual. Behavior stayed the same

o.o

o.o

Grooming Self decreased

2.0 :I: .2

0.0

Being Groomed decreased

0.2 :I: .2

o.o

Grooming Other decreased

0.5 :I: .3

0.0

Aggression decreased

1.5 :I: .4

o.o

Chart 12a

'
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Experiment XII

All animals slept for most of this experiment.
slowly, but were not in a catatonic state.

They were moving

No ataxia was observed.

The

animals were wet ventrally when placed in the chamber, but body temperature
was normal (42 degrees C) for this strain.
around the genitalia.

A viscous substance, appeared

No piloerection or shaking was observed.

Biochemically a NE and DA. decrease was seen.
due to the low norepinephrine.

Sleeping may

been

hav~

It is interesting to note that the direct

effect of L-Dopa (described earlier) relating to catatonia was not seen.
This may have been due to the low norepinephrine or due to some other
effect

of~MPT

which blocked the L-Dopa effect.

L-Dopa clearly had a

pronounced catatonic effect when used with Pargyline with or withoutcia.MPT
(Exp. IV and XI respectively) and when used in the same dose alone.
catatonia seen after L-Dopa administration was prevented

by~MPT

The

when no

monoamine oxidase inhibitor was given seemingly.irrespective of amine or
5HT levels.
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Experiment XIII

J

I

DOSAGE AND DRUGS

I
I

CPlO 316 mg/kg.
CPlO daily for four consecutive days.

Biogenic Amine Levels
% change from controls
Ill\

- 5

not sig.

NE

- 3

not sig.

E

- 1

not sig.

5HT

- 60

P.<.01

Chart 13

.._------~-------------~--------~----------------------------------------
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Experiment XIII

COMPARISON WITH CONTROL "CITY" EXPER.lMENTS

TRAITS

NUMERICAL INDEX
CONTROL

DRUGGED

Explorati on decreased

1 .. 0 ± .8

4.o·± .3

Digging de creased

0.3 ± .3

o.o

Stereot:ypic Behavior decreased

0.1 ± .1

0.0

Sleeping r emained same

2.0 ± .1

2.0 ± .2

Freezing decreased

0.1 ± .2

0.0

Contactual Behavior increased

0.1 ± .1

0.2 ± .1

Ingestion increased

0.5 ± .3

4.0 ± .4

Sexual Beh avior remained the same

o.o

0.0

Grooming Self decreased

2.0 ± .2

1.0 ± .1

Being Groomed decreased
..
Grooming Other decreased

0.2 ±. .2

o.o

0.5 ± .3

0.0

Aggression remained the same

1.5 ± .4

1.5 ± .6

~art

!
I.

13a

l
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Experiment XIII

I
f

The animals were depressed throughout the experiment.

lnoticed.

No piloerection or shaking occurred.

No ataxia was

Body temperature was nor-

mal (42 degrees C) for this strain.
5HT level decreased markedly, as expected.

A correlation between

,5HT and sleep is discussed in a following section (Chapter V).

I

One specific and interesting finding is the great increase in ingestive

behavior.

Eating has been related to brain norepinephrine stimulation;

drinking to a cholinergic system (Miller, 1965).

CP-10 did not increase

any of the adrenergic or serotonergic transmitters but it did increase
appetitive behavior.

It must be presumed that the increased ingestion was

not the result of a change in amine level by CP-10, but rather it is a
direct drug effect.
CP-10 has been reported to facilitate sexual·mounting behavior in
rats and .rabbits (Tagliamonte et al., 1969; Ferguson et al., 1970).

These

studies indicated that CP-10 may heighten homosexual mounting behavior.
Later studies showed however that CP-10 would not heighten male-female_
sexual mounting and may alter the males ability to distinguish appropriate
sexual partners (Whalen and Luttage, 1970).

Our data do not substantiate

facilitation of homosexual behavtor in male mice.

74

Experiment XIV

DOSAGES AND DRUGS

CPlO

316 mg/kg. ;..MPT 80 mg/kg

CPlO daily for four consecutive days.
- TID q 4 hours for one day and one hour before experiment.

Biogenic Amine Levels

% Change from Controls
DA

- 99

P.<.01

NE

- 95

P.<.01

E

- 10

not sig.

SHT

- 60

P.<.01

~Chart

14

r
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Experiment XIV

CCM.PARISON WITH CONTROL "CITY'' EXPERIMENTS

NUMERICAL INDEX

TRAITS

COOTROL

DRUGGED

Exploration decreased

7·.0 ± .8

4.0 ± .3

Digging decreased

0.3 ± .3

0.0

Stereotzyic Behavior decreased

0.1 ± .1

o.o

Sleeping increased

2.0 ± .1

9.0 ± .2

Freezing decreased

0.1 ± .2

o.o

Contactual Behavior decreased

0.1 ± .1

0.0

Ingestion increased

0.5 ± .3

3.0 ± .9

Sexual Behavior remained the same

o.o

0.0

IGrooming Self decreased

2.0 ± .2

0.0

Being Gr?Ollled decreased

0.2 ± .2

0.0

Grooming Other decreased

0.5 ± .3

Aggression decreased

1.5 ± .4

o.o
o.o

r
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Experiment XIV

All of the animals were depressed throughout the experiment.

j

iwas much sleeping and ingestion.

ntere

Piloerection was noticed in 50% of the

animals for the first half-hour of the experiment.

No ataxia was noticed.

All of the animals were wet ventrally and a viscous substance much thicker
than urine was noticed surrounding the genitalia.

'normal (42 degrees C)
·

fo~

Body temperature was

this strain.

Many of the effects·, described in earlier experiments, the increased
appetite, the ventral wetting, increased sleeping and depression, were
seen in this experiment.

nie ventral wetting and genital substance may

be caused by J.,MPT, the high ingestion may be related to CP-10, the cause
of sleeping and depression is obscure, and will be discussed in a following
section (Chapter V).

I

I
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Experiment XV

DOSAGES AND DRUGS

CPlO

316 mg/kg, Pargyline 100 mg/kg.

5HT 100 mg/kg.

ie--MPT 80 mg/kg

CPlO:

daily for four consecutive days

Pargyline:
5HTP:
~MPT:

24 hours before experiment

15 minutes before experiment
TID q 4 hours for one day and one hour before experiment

Biogenic Amine Levels
% Change from controls
DA

- 95

p .<. 01

NE

- 99

P.<.01

E

- 4

not sig.

SHT

+ 226

P.<.001

Chart 15
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Experiment XV

COMPARISON WITH COOTROL "CITY" EXPERIMENTS

II

TRAITS

NUMERICAL INDEX

I

CONTROL

DRUGGED

7.0 ± .8

0.0

Digging decreased

0.3 ± .3

0.0

StereotyPic Behavior decreased

0.1 ± .1

0.0

SleeEing decreased

2.0 ± .1

0.0

Freezing decreased

0.1 ± .2

Contactual Behavior decreased

0.1 ± .1

o.o
o.o

0.5 ± .3

0.1

Sexual Behavior stayed the same

o.o

0.0

Grooming Self decreased

2.0 ± .2

0.0

Being Groomed decreased

0.2 ± .2

o.o

Grooming Other decreased

0.5 ± .3

o.o

Aggression decreased

1.5 ± .4

0.0

IExploration decreased

· Ingestion decreased

I

l
I

I
I
l

!

Chart 15a
(
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Experiment XV

All animals were paralyzed in their hindlimbs.
hindlimbs were abducted in a "spread eagle" fashion.
extremely irritable and excited.

Both forelimbs and
All animals were

There appeared quick, jerky movements

of the head accompanied by constant sniffing of the ground.
was noticed in all animals.

Piloerection

The animals seemed to rotate on their hind-

limbs and had respiration problems characterized by hacking and irregular
breathing.

The animals were dry ventrally.

Body temperature was normal

(42 degrees C) for this strain.
Excitement and strong activity is present although the NE level is
quite low: the abduction presumed on occasion related to serotonin is
present although serotonin is lower than levels which do
other experiments.

!!2!

~

it in

The relationship between the paralysis seen in this

experiment and the pattern of amines and serotonin is discussed in the
· following chapter (Chapter V).
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Chapter V
GENERAL DISCUSSION

I

In this study there are three behavioral states which need further

tclarification and sunnnary.
lparalysis and sleeping.

I

These behavioral states are catatonia,

Because of the large amount of data the behavioral

f and biochemical results will be presented together on three tables.
Table III shows the drugs used, the amine concentration expressed

as percent change from control, and one of the quantitated behavioral
traits expressed as the average number of checks per experiment per mouse .
. It can be seen from Table III that the administration of L-Dopa alone
resulted biochemically in a significant increase in DA and NE.

As indicated

in the results section the animals were in a state of catatonia, i.e.
(the animals assumed a rigid position and would not move) for an average
of 10 out of 15 checks,

This behavior is absent in the control animals.

Administration of Pargyline alone resulted in an increase in DA, NE and
SHT in excess of that seen when L-Dopa alone was administered, yet no
catatonia was seen.

Perhaps the increase in SHT seen after administration

of Pargyline alone may have counteracted the catatonia resulting from
the administration of L-Dopa alone.

However, after the administration

of Pargyline and Dopa together an increase in Ill\, NE, and SHT resulted .
which was greater than that seen from either drug alone, yet the animals
were again in a state of catatonia similar to the animals which had received L-Dopa alone.

A 5HT increase had no counteracting effect.

There

seems to be no proof that the amines are modulating this catatonia for
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TABLE III

Effect of Drugs on DA, NE and SHT Levels
and Catatonia.

TABLE IV

Effect of Drugs on DA, NE and SHT Levels
and Paralysis.

TABLE V

Effect of Drugs on DA, NE and SHT Levels
and Sleep.
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nowhere in our data do we find this behavioral state without the administration of Pargyline and 9HTP resulted in an increase in DA, NE and
5HT in a manner quite similar to the catatonia producing drugs, yet no
catatonia was seen.

Yet catatonia was seen after the administration of

Pargyline, J..MPT and L-Dopa, and here the amine levels are similar to
those levels which did not cause catatonia.

Perhaps catatonia was due

to an effect of the drug, L-Dopa on the central nervous system (CNS) of
the animals.
with ..lMPT.

However, no catatonia was seen

whe~

L-Dopa was administered

Here, however, the amines are very low.

It seems, therefore,

that L-Dopa has an effect of its own on the CNS: it has such an effect
only when the amines are at a high optinum level.
Table IV shows that there was a significant increase in SHT after the
administration of 5HTP.
cant after this drug.

The change in DA and NE, however, was not signifiDA, NE and 5HT were all significantly increased

after the administration of Pargyline.

The behavior of the animals re-

ceiving these two drugs alone was in no way different from the behavior
of the saline control animals (Exps. III, V).
receiving

t~ese

However, all the animals

two drugs together (Pargyline and 5HTP)

exhibi~ed

of the head and forepaws as described in the results section.
lay in a "spread eagle" fashion for most of the experiment.
levels of DA, NE and 5HT are

al~

a tremor

The animals
Although the

increased with this combination, the

increase in 5HT is greater than that produced by 5HTP or Pargyline alone.
A tremor and paralysis was also produced as a result of the administration
of Pargyline, J..MPT and 5HTP together.

However, the DA and NE levels were

reduced whereas the 5HT level was increased to 400% of control.

It could
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be assumed at this point that the extremely high levels of 5HT (425%
of control in the first case and 400% of control in the second) may be
implicated as a causal factors in the paralysis.

However, subsequent

experiments reveal a similar change in amines after administration of
Pargyline andJ..MPT.

In this case, however, no tremor or paralysis was

seen although there was an increase in 5HT to 380% of the control value,
and the levels pf NE and DA are very similar to those levels which were
accompanied by the paralysis.
It may be that 5HTP is exerting a direct effect to cause the paralysis.
It has this effect only when the level of 5HT is at a critical level.
Table V shows that after the administration of d...MPT, the animals
suffered a significant loss of NE and DA.
affected.

5HT in this experiment was not

Behaviorally the animals slept for an average of 10 out of

15 checks.

The control value for sleeping is two out of a total of fifteen

checks.
Per~aps

of J..MPT.

low NE and DA was responsible for the sleep producing effect

Branchey (1970) found that a single intraperitoneal injection

of 200 mg/kg d-alpha-methyl-para-tyrosine in the rat induced a significant
increase in NREM sleep without affecting REM sleep.

On the other hand,

Ban (1969) showed that increased brain levels of DA are associated with
sedative effects whereas both 04. and 5HT levels were associated with
hypnotic effects.

The two effects may be differentiated by a marked

increased 5HT level for hypnotic effects and to a lesser extent by increases of DA and NE.

l
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The effects of administration of Reserpine on NE and DA are well

lknown, and a direct relationship between low NE and DA levels and the

f

'sedative effects of Reserpine is presumed by many authors (Introduction).
However, because Reserpine also depletes 5HT, controversy has arisen in
the past over the importance of 5HT and the catecholamines in Reserpine
induced sedation.

However, Reserpine induced sedation without depletion

of 5HT has been reported by Gal and Millard ·(1967).
Table III also shows that after the administfation of CPlO alone

DA and NE levels

no change from control in sleeping behavior was noticed.

were normal, but the 5HT level was decreased after administration of this
drug.
After administration of CPlO and .,1..MPT together the animals showed an
increase in sleeping behavior over the control animals.

The drugged

animals sleJtfor an average of nine out of a total of fifteen checks.
DA, NE and 5HT were all decreased.

So far then the increase in sleeping

.behavior. occurs whenever there is an accompanying low level of both DI\
and NE, regardless of the levels of 5HT.

The level of 5HT seems to be

unimportant .so far, i.e. after administration of J.-MPT alone it was normal
and after CPlO and J..MPT together it was decreased, yet in both of these
experiments an increase in sleeping behavior was seen.

However, after

administration of Pargyline and"'-MPT together a decrease in sleeping was
seen although DI\ and NE levels were again decreased and the 5HT level was
increased.

The administration of Pargyline, CPlO

and~

and 5HT to-

gether produced similar changes in amines and sleeping behavior.

It

would seem then that the high 5HT level counteracted the sedating effect

·-----~------------------------------------------------------------------------"

I

.... ,

-----

.----..,.,,,......

I of low DA. and NE.

~,.._.,,,,

________________
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Hery et al. (1970) found an increased 5HT synthesis

induced by paradoxical sleep deprivation.

This seemed to be the result

of increased uptake of tryptophan as well as increased conversion to 5HT.
His results supported the hypothesis that serotonergic neurons are involved in paradoxical sleep processes.

Delorme et al. (1966) showed that

chronic serotonin depletion by PCPA (CPlO) is accompanied by a transitory
insomnia, the emergence of lateral geniculate spikes into wakefulness, and
global behavioral changes including hypersexuality, irritability, and
increased aggressiveness.
Our hypothesis, that the high serotonin counteracted the sedative
effect of low NE and DA was tenuous because the administration of

J..MPT

and 5HTP produced a change in amines almost exactly the same as that
produced by Pargyline andd--MPT together.
DA and an increase in 5HT.

That is, a decrease in NE and

Sleeping was increased in this case and the

high 5HT level had no counteracting effect.
Slee~ing

may be due to a direct drug effect·, i.e. J...MPT produces

sedation except when administered alone with Pargyline.

Such a drug inter-

action is the only simple hypothesis this data permits.

Low levels of DA

and NE, then, do not seem to be a reliable index of sedation and sleep as
postulated earlier.
Miller (1965) in a preliminary report suggested that the balance of
free 5HT/NE was the deciding factor in behavioral depression induced by
the benzoquinolizines.

He suggested that the preponderance of free

5HT/NE resulted in sedation.
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Chapter VI
CONCWSIOO

It is known that microinjection of different drugs in identical brain
areas will elicit different discrete behavioral acts {Miller, 1965).

It

has also been shown that the drug systematically injected may have a behavioral effect opposite to that of a selective placement by microinjection
in the brain (Gal and Millard, 1967).
disadvantages:

Our present studies have several

1) The drugs are injected systemically and the observed

changes in amines may differ from fluctuations in amines brought about by
local injection.

2) The behavioral parameters which were studies are often

obliterated by the toxic effects of individual drugs.
brain p•rts were not determined.

3) Amine changes in

Indeed, the amine levels are determined

for whole brain and presumably the biogenic amine levels have changed
everywhere at varying rates of synthesis or depletion, both bound and unbound.

Therefore it is still possible, even if.clear cut behavioral modu-

lation is not seen in these experiments that chemical coding of behavior
exists.

Certainly hormonal effects on behavior are well established

(Miller, 1965) and sintequantitation of mental stress by an analysis of
urinary catecholamine levels is possible (Von Euler, 1964), there must be
a close correlation if not a cadsal relationship.
Behaviorally, in some parameters, widely different chemical agents
may be similar in effects.

Thus atropine and scopolamine, MAO!, pheno-

thiazines, codeine and antihistaminics, may reverse aggressive behavior
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at low, non-toxic doses (Da Vanzo et al., 1968).

It is well known that

different central acting drugs; bemegride, morphine, alcohol and many
others show selective action on different centers, circuits, systems or
cell populations in the brain.

There may or may not be a transmitter

basis for the behavioral effects of these drugs.

The effects may be due

to a change in irritability of certain neurons selectively.
On the basis of the lack of consistant correlation between amines of

whole brain and behavior and the great f luctuation'.s of amine levels
measured in these experiments, it is unlikely that changes in the levels
of the biogenic amines alone could give much insight on complex mechanisms
involved in behavior.

Whereas the effects of these amines at particular

sites in the brain probably are of crucial importance in the regulation
of behavtor, any fornulation of the physiology of behavior would have to
include other biochemical, physiological and psychological factors.
Sumnary
The·(whole mouse brain) levels of norepinephrine, epinephrine,
serotonin, dopa and dopamine were varied more or less selectively by means
of suitable injection schedules and combinations of parachlorophenylalanine
L-Dopa, 5-hydroxytryptophane, pargyline and a-methyl-p-tyrosine.

The

amines and serotonin were extracted and determined spectrophotoflourometrically according to the tecl\nique of Weigand and Perry (Biochem. Pharm ..
7: 181-6, 1961).

The extraction was made at the mid point in time during

which the behavior of similarly treated animals was quantitated.
The behavior (of the mice) was quantitated using a "Mouse City"
set-up made of plexiglass.

It is composed of six small home cages
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(5" x 7" x 4") each connecting with a central conmunal chamber (18" x
11" x 611 ) by means of funnel-like, cylindrical runways.

In the city

experiment, two aggregated males, after suitable drug pre-treatment, were
placed in each of the small cages of the "city".
•

The animals were sub-

sequently allowed to freely interact with one another and at five minute
intervals were checked for the following behavioral parameters:
digging, stereotypic behavior, food-carrying-, sexual behavior,

exploration,
fr~ezing,

sleeping, contactual behavior and aggression.
No completely satisfactory correlation was found between any single
amine level or ratio of amine levels and behavior.

Three predominant be-

haviors emerged from these studies; catatonia, sleep and paralysis.
The effect of the drugs on other behaviors is discussed in reference
to these three behaviors.

The effects on behavior seen in these experi-

ments by and large are presumed to be due either to direct drug effects
or to effects of drugs on other neurohmnors or .systems not measured in
this study.

Catecholamines and Serotonin did not in general prove to be

reliable indexes of any behavior nor did levels of the amines or serotonin
give predictable behavioral responses.
The work presented in this thesis was helpful in clearing the way for
a better understanding of which behaviors and what aspects of brain function
are regulated by the

neurohumors~and

although the results are largely neg-

ative they were invaluable for a constructive interpretation in later research for a Doctorate Dissertation.
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